Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method

The SARS-CoV-2 outbreak caused an unprecedented global public health threat, having a high transmission rate with currently no drugs or vaccines approved. An alternative powerful additional approach to counteract COVID-19 is in silico drug repurposing. The SARS-CoV-2 main protease is essential for v...

Descripción completa

Detalles Bibliográficos
Autores principales: Sencanski, Milan, Perovic, Vladimir, Pajovic, Snezana B., Adzic, Miroslav, Paessler, Slobodan, Glisic, Sanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503980/
https://www.ncbi.nlm.nih.gov/pubmed/32842509
http://dx.doi.org/10.3390/molecules25173830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503980/
https://www.ncbi.nlm.nih.gov/pubmed/32842509
http://dx.doi.org/10.3390/molecules25173830

Ejemplares similares